Table 4.
Estimated resource utilisation and budget required for a national screening programme of the most cost-effective strategies in PNG. (A) Average annual resources§ required for a national screening program in PNG estimated over the first 5 years of implementation (2023–2027). (B) Estimated total budget* (US$) over the first 5-year and 10-year periods †
| (A) Annual resource utilisation§ | No screening | 1X at age 35 self-collected HPV S&T | 2X at age 35 and 40 self-collected HPV S&T | 2X at age 30 and 40 self-collected HPV S&T | 2X at age 35 and 45 self-collected HPV S&T‡ | 3X at age 30, 35 and 40 self-collected HPV S&T | 5-yearly 30–55 self-collected HPV S&T (6X) |
| No of HPV tests | 0 | 42 500 | 78 200 | 83 800 | 71 400 | 124 900 | 197 400 |
| No of women diagnosed with precancerous lesions and eligible for ablation | 0 | 5892 | 8802 | 12 391 | 8186 | 16 147 | 20 484 |
| No of women diagnosed with cervical cancer through symptomatic presentation | 1085 | 974 | 900 | 907 | 913 | 854 | 726 |
| No of women diagnosed with cervical cancer through screening | 0 | 53 | 89 | 88 | 108 | 108 | 193 |
| No of women diagnosed with precancerous lesions but ineligible for ablation | 0 | 58 | 83 | 110 | 84 | 130 | 182 |
| (B) Budget * | No screening | 1X at age 35 self-collected HPV S&T | 2X at age 35 and 40 self-collected HPV S&T | 2X at age 30 and 40 self-collected HPV S&T | 2X at age 35 and 45 self-collected HPV S&T‡ | 3X at age 30, 35 and 40 self-collected HPV S&T |
5-yearly 30–55 self-collected HPV S&T (6X) |
| 5-year budget (2023–2027) | 1.9M | 6.9M | 10.9M | 11.9M | 10.2M | 16.5M | 24.8M |
| 10-year budget (2023–2032) | 3.8M | 13.9M | 21.3M | 23.4M | 20.3M | 31.7M | 46.9M |
*5-year and 10-year budgets were calculated as the financial costs (US$, 2019) associated with cervical cancer screening, diagnosis, and treatment over the first 5 years (2023-2027) and 10 years (2023-2032) of implementation. This budget is a broad estimate of that required for a future national cervical cancer screening programme in PNG (inflation was not considered).
†We used UN population structure estimated for PNG (year 2020) and assumed this population structure remained over 2023–2032 to estimate budget and resources.
‡WHO recommendation for cervical screening for cervical cancer elimination.
§ Annual resources for a national cervical screening program in PNG were estimated as an average of the resources required over the first 5 years of implementation (2023-2027)
PNG, Papua New Guinea; S&T, screen and treat.